Skip to content
Tenderpatch

NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)

Leeds Teaching Hospitals NHS Trust

Open Closes in 45 days

Key facts

Closing date
Monday 30 November 2026, 12:00 (UK time) Closes in 45 days
Buyer's estimated value
£36,095,687 (excl. VAT) The buyer's own estimate, not income to you. For a framework this usually covers the whole agreement, not a single contract.
Clarification questions deadline
6 November 2026, 12:00
Contract period
30 Apr 2027 to 31 Dec 2028
Procedure
Competitive flexible procedure
Notice type
Tender notice (UK4)
Suitable for SMEs (per buyer)
Yes
Arrangement
Framework agreement

Decision brief

Taken from the buyer's published notice (shown as written, shortened where long). Tenderpatch has not added to or interpreted it. Always read the official documents before bidding.

How bids will be scored
  • Technical Quality 30% : Bidder specification (Technical Quality) 30% and Pass / Fail Mandatory requirementselements)
  • Social Value Sustainability 10% : Bidder Specification (Social Value and sustainability) - 10% weighted scoring
  • Commercial 60% : Commercial Evaluation (Price) - 60% weighted scoring
Conditions of participation (what you must show)
None published in the notice. They may be in the tender documents.
Contract length and extensions
30 Apr 2027 to 31 Dec 2028. Extensions: optional 12 month extension
How to submit
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@ata… Open health-family.force.com ↗ Electronic submission: allowed.
Tender documents

Invitation to Tender for Unlicensed Imported Medicines ↗ (atamis-1928.my.site.com)

New to public tenders? Plain-English guide to this page
Framework
An agreement that sets terms for work the buyer may order later, often from several suppliers. The value shown usually covers the whole agreement, not one job.
Open for bids / closing date
You must submit by the closing date and time, normally through the buyer's own online portal. Late bids are normally refused.
Clarification questions
A deadline for asking the buyer questions about the tender. It is earlier than the closing date.
Conditions of participation
What the buyer asks suppliers to show before they can be considered, such as experience, insurance or accreditations.
Bids are scored on
How the buyer will compare bids, usually a split between price and quality. A 60/40 split in favour of quality means the cheapest bid will not necessarily win.
Lots
A tender can be split into parts. You can often bid for only the lots that suit you.
Area (ITL)
The buyer names an official statistical area for where the work is, not a street address. Check the tender documents for the actual sites.
UK4 and other notice codes
Official codes for the type of notice. A "tender notice" means bids are being invited.

General explanations written by Tenderpatch, not part of this notice.

Description

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a framework agreement for the supply of Unlicensed Imported Medicines on behalf of NHS organisations and other eligible public sector bodies. The framework will provide access to a defined range of unlicensed imported medicines, including products requiring over-labelling and translation. These medicines do not hold a UK Marketing Authorisation but are licensed in their country of origin and may be imported and supplied in accordance with Regulation 167 of the Human Medicines Regulations 2012 where a patient's clinical needs cannot be met by a suitable licensed alternative. Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK, and to demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. The framework will provide participating organisations with access to safe, compliant and quality-assured products through a robust and competitive procurement arrangement. Products and suppliers will be subject to comprehensive quality, risk and commercial assessment to support regulatory compliance, supply chain resilience, continuity of patient care and value for money across the NHS.